$BLPG
Blue Line Protection Group, Inc. Stock $blpg

$blpg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017115 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.105M	$1.009M	$1.000M
YoY Change	12.15%	0.88%	-14.25%
Cost Of Revenue	$367.7K	$360.9K	$283.1K
YoY Change	18.37%	27.49%	-7.07%
Gross Profit	$736.8K	$648.1K	$717.2K
YoY Change	9.29%	-9.62%	-16.79%
Gross Profit Margin	66.71%	64.23%	71.7%
Selling, General & Admin	$559.9K	$552.1K	$513.5K
YoY Change	3.28%	7.51%	2.36%
% of Gross Profit	75.98%	85.19%	71.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$33.48K	$34.92K	$24.08K
YoY Change	0.89%	45.02%	-15.3%
% of Gross Profit	4.54%	5.39%	3.36%
Operating Expenses	$559.9K	$552.1K	$513.5K
YoY Change	3.28%	7.51%	2.36%
Operating Profit	$177.0K	$96.01K	$203.6K
YoY Change	33.94%	-52.85%	-43.47%
Interest Expense	$55.44K	$43.50K	-$353.8K
YoY Change	-26.05%	-112.29%	-84.59%
% of Operating Profit	31.32%	45.31%	-173.77%
Other Income/Expense, Net	-$46.08K	-$101.6K	-$353.8K
YoY Change	-185.64%	-71.29%
Pretax Income	$130.9K	-$5.570K	-$150.2K
YoY Change	-29.59%	-96.29%	-92.24%
Income Tax
% Of Pretax Income
Net Earnings	$130.9K	-$5.565K	-$150.2K
YoY Change	-29.6%	-96.3%	-92.24%
Net Earnings / Revenue	11.85%	-0.55%	-15.02%
Basic Earnings Per Share	$0.02	$0.00	-$0.02
Diluted Earnings Per Share	$0.02	$0.00	-$17.77K
COMMON SHARES
Basic Shares Outstanding	8.250M shares	8.250M shares	8.451M shares
Diluted Shares Outstanding	13.04M shares	8.250M shares	8.451M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$413.1K	$409.3K	$591.8K
YoY Change	-29.36%	-30.83%	11.85%
Cash & Equivalents	$413.1K	$409.3K	$591.8K
Short-Term Investments
Other Short-Term Assets	$33.60K	$31.55K	$31.07K
YoY Change	7.66%	1.54%	-14.1%
Inventory
Prepaid Expenses
Receivables	$386.1K	$336.6K	$322.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$832.7K	$777.5K	$945.3K
YoY Change	-8.83%	-17.75%	-3.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$843.6K	$598.0K	$761.5K
YoY Change	3.47%	-21.47%	-13.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$34.70K	$34.70K	$31.74K
YoY Change	-5.55%	9.33%	0.0%
Total Long-Term Assets	$875.5K	$629.9K	$793.3K
YoY Change	7.39%	-20.59%	-12.93%
TOTAL ASSETS
Total Short-Term Assets	$832.7K	$777.5K	$945.3K
Total Long-Term Assets	$875.5K	$629.9K	$793.3K
Total Assets	$1.708M	$1.407M	$1.739M
YoY Change	-1.19%	-19.04%	-8.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$564.0K	$616.5K	$807.0K
YoY Change	-29.62%	-23.6%	-45.28%
Accrued Expenses	$91.18K	$77.85K	$139.0K
YoY Change	-30.14%	-43.99%	24.6%
Deferred Revenue
YoY Change
Short-Term Debt	$714.5K	$583.2K	$966.3K
YoY Change	-23.07%	-39.65%	-64.81%
Long-Term Debt Due	$22.55K	$177.3K	$28.11K
YoY Change	-59.67%	530.67%	-47.39%
Total Short-Term Liabilities	$1.845M	$1.940M	$2.752M
YoY Change	-27.84%	-29.51%	-67.64%
LONG-TERM LIABILITIES
Long-Term Debt	$914.6K	$976.8K	$1.172M
YoY Change	-20.54%	-16.67%
Other Long-Term Liabilities	$592.8K	$328.1K	$397.1K
YoY Change	58.08%	-17.37%	-25.93%
Total Long-Term Liabilities	$1.507M	$1.305M	$1.569M
YoY Change	-1.21%	-16.84%	192.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.845M	$1.940M	$2.752M
Total Long-Term Liabilities	$1.507M	$1.305M	$1.569M
Total Liabilities	$3.352M	$3.245M	$4.321M
YoY Change	-17.89%	-24.91%	-52.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.84M	-$11.97M
YoY Change	1.76%
Common Stock	$8.251K	$8.251K
YoY Change	-2.77%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.644M	-$1.837M	-$2.583M
YoY Change
Total Liabilities & Shareholders Equity	$1.708M	$1.407M	$1.739M
YoY Change	-1.19%	-19.04%	-8.04%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$130.9K	-$5.565K	-$150.2K
YoY Change	-29.6%	-96.3%	-92.24%
Depreciation, Depletion And Amortization	$33.48K	$34.92K	$24.08K
YoY Change	0.89%	45.02%	-15.3%
Cash From Operating Activities	$89.36K	$218.9K	$238.9K
YoY Change	-13.93%	-8.41%	-26.18%
INVESTING ACTIVITIES
Capital Expenditures	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-85.62K	-$89.58K	-309.3K
YoY Change	-14.17%	-71.04%	685.7%
NET CHANGE
Cash From Operating Activities	89.36K	$218.9K	238.9K
Cash From Investing Activities	0.000
Cash From Financing Activities	-85.62K	-$89.58K	-309.3K
Net Change In Cash	3.740K	$129.3K	-70.39K
YoY Change	-153.05%	-283.65%	-124.76%
FREE CASH FLOW
Cash From Operating Activities	$89.36K	$218.9K	$238.9K
Capital Expenditures	$0.00
Free Cash Flow	$89.36K	$218.9K
YoY Change	-22.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001416697
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Notes Payable Current Related And Nonrelated Party Status Extensible Enumeration NotesPayableCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4	us-gaap	Notes Payable Noncurrent Related And Nonrelated Party Status Extensible Enumeration NotesPayableNoncurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q1	BLPG	Stock Option Expense StockOptionExpense		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding		usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-52942
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BLUE LINE PROTECTION GROUP, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5543728
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5765
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Denver
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80216
CY2023Q1	dei	City Area Code CityAreaCode	(800)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	844-5576
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8250144	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409343	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	280073	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	336641	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	373175	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31553	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	31553	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	777537	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	684801	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375915	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	408616	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	219307	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254227	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	598004	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	665625	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	31920	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	31920	usd
CY2023Q1	us-gaap	Assets Assets	1407461	usd
CY2023Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2022Q4	us-gaap	Assets Assets	1382346	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	616526	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	555445	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	24508	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	31719	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	152771	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	152771	usd
CY2023Q1	BLPG	Convertible Notes Payable Related Parties Current Net Of Unamortized Discount ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount	583191	usd
CY2022Q4	BLPG	Convertible Notes Payable Related Parties Current Net Of Unamortized Discount ConvertibleNotesPayableRelatedPartiesCurrentNetOfUnamortizedDiscount	604256	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77845	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112250	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	485119	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1939960	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1907560	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	31836	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	37568	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	944927	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1000500	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1304879	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1366184	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3244839	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3273744	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	20000	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	20000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8250144	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8250144	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8250144	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8250144	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	8251	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8251	usd
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2023Q1	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2023Q1	BLPG	Stock Option Expense StockOptionExpense	35510	usd
CY2022Q4	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2023Q1	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2022Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	129	shares
CY2023Q1	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2022Q4	BLPG	Common Stock Owed But Not Issued CommonStockOwedButNotIssued	13	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10105681	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10046096	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11971323	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-11965758	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1837378	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1407461	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1382346	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1009066	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1000256	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	360927	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	283105	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	648139	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	717151	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	552132	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	513541	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	552132	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	513541	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	96007	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	203610	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	43497	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	65768	usd
CY2023Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-58075	usd
CY2022Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-288053	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-101572	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-353821	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5565	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-150211	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8250144	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8451144	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8250144	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8451144	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5565	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-150211	usd
CY2023Q1	us-gaap	Depreciation Depreciation	34920	usd
CY2022Q1	us-gaap	Depreciation Depreciation	24081	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32701	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28895	usd
CY2023Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	58075	usd
CY2022Q1	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	288053	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-36534	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5574	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3309	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61081	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	68779	usd
CY2023Q1	BLPG	Increase Decrease In Lease Obligation IncreaseDecreaseInLeaseObligation	34405	usd
CY2022Q1	BLPG	Increase Decrease In Lease Obligation IncreaseDecreaseInLeaseObligation	29542	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	218851	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	238938	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	21064	usd
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	300698	usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	55574	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	12943	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	8631	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-89581	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-309329	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	129270	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-70391	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	280073	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	662177	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	409343	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	591786	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	20700	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	9914	usd
CY2023Q1	BLPG	Derivative Resolution DerivativeResolution	24075	usd
CY2022Q1	BLPG	Derivative Resolution DerivativeResolution	189265	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2621605	usd
CY2022Q1	BLPG	Adjustments To Additional Paid In Capital Derivative Resolution AdjustmentsToAdditionalPaidInCapitalDerivativeResolution	189265	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-150211	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-2582551	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1891398	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	35510	usd
CY2023Q1	BLPG	Adjustments To Additional Paid In Capital Derivative Resolution AdjustmentsToAdditionalPaidInCapitalDerivativeResolution	24075	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5565	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1837378	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1837378	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	56344	usd
CY2019Q1	us-gaap	Debt Instrument Interest Rate Increase Decrease DebtInstrumentInterestRateIncreaseDecrease	0.12	pure
CY2006Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2006Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On May 6, 2014, the Company effected a forward stock split and a pro-rata increase in its authorized common stock on a basis of 14-to-1, whereby each shareholder received 14 newly issued shares of common stock for each 1 share held
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2022Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	137500	usd
CY2022Q1	us-gaap	Debt Instrument Periodic Payment Principal DebtInstrumentPeriodicPaymentPrincipal	12500	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zIbeurayuda7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z8NpZ1XyFC39">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	150124	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<p id="xdx_840_eus-gaap--FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_z1jSaH8SQLm1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zhozWW3xZSbg">Allowance for uncollectible accounts</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company estimates losses on receivables based on known troubled accounts, if any, and historical experience of losses incurred. There was <span id="xdx_908_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20230331_z84XJifjL4x6" title="Allowance for doubtful receivables"><span id="xdx_907_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_do_c20221231_zZuolWzNWzE4" title="Allowance for doubtful receivables">no</span></span> allowance for doubtful customer receivables at March 31, 2023 and December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q1	us-gaap	Depreciation Depreciation	34920	usd
CY2022Q1	us-gaap	Depreciation Depreciation	24081	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zCbKt9KBbk69" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zeizgo9ETiQi">Concentration of business and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has no significant off-balance sheet risks such as foreign exchange contracts, option contracts or other hedging arrangements. The Company’s financial instruments that are exposed to concentration of credit risks consist primarily of cash. The Company maintains its cash in bank accounts, which may at times, exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNdQBH1lmpn6" title="Concentration credit risk, percentage">10.4</span>% of total revenue for the three months ended March 31, 2023 and one customer comprised <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230331__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zbl4mFUKDjh1" title="Concentration credit risk, percentage">18.9</span>% of the account receivable balance at March 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had one major customer which generated <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zeaJwtRtIda8" title="Concentration credit risk, percentage">27.8</span>% of total revenue for the three months ended March 31, 2022 and one customer comprised <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--OneMajorCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zZ69Fq4RIgwd" title="Concentration credit risk, percentage">36.9</span>% of the account receivable balance at March 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	485119	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	485119	usd
CY2022Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	451119	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023Q1	us-gaap	Revenues Revenues	1009066	usd
CY2022Q1	us-gaap	Revenues Revenues	1000256	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	4020	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	24508	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	31386	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4797429	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3107500	shares
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	34346	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	34346	usd
CY2023Q1	BLPG	Operating Right Of Use Assets Lease OperatingRightOfUseAssetsLease	375915	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	375915	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77845	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	405961	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	32701	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	12343	usd
CY2023Q1	BLPG	Finance Lease Expense FinanceLeaseExpense	45044	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	34405	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	124513	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	138532	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	141302	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	107558	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	511905	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	105944	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	405961	usd
CY2022Q4	BLPG	Operating Right Of Use Assets Lease OperatingRightOfUseAssetsLease	408616	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	408616	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	112250	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	328116	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	440366	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12	pure
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	121095	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6673	usd
CY2022	BLPG	Finance Lease Expense FinanceLeaseExpense	127768	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	125266	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958660	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	958660	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	739353	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	704433	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	219307	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	254227	usd
CY2023Q1	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipment	2782	usd
CY2023Q1	us-gaap	Depreciation Depreciation	34920	usd
CY2022Q1	us-gaap	Depreciation Depreciation	24081	usd
CY2022Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	137500	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075	pure
CY2022Q3	BLPG	Accrued Interest Debt Forgive AccruedInterestDebtForgive	250000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.075	pure
CY2022Q3	BLPG	Default Rate Percentage DefaultRatePercentage	0.12	pure
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	712784	usd
CY2021	BLPG	Settlement Of Derivatives Upon Conversion SettlementOfDerivativesUponConversion	-442389	usd
CY2021	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	180724	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	451119	usd
CY2023Q1	BLPG	Settlement Of Derivatives Upon Conversion SettlementOfDerivativesUponConversion	-24075	usd
CY2023Q1	us-gaap	Derivative Fair Value Hedge Included In Effectiveness Gain Loss DerivativeFairValueHedgeIncludedInEffectivenessGainLoss	58075	usd
CY2023Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	485119	usd
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2014Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2021Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	On July 6, 2021, the Company effected a reverse stock split and a pro-rata decrease in its authorized common stock on a basis of 1-for-100, the authorized capital of the Company concurrently decreased to 14,000,000 shares of common stock.
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	14000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3022000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.21
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	17500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0.21
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3004500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.21
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1541000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.21
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.21
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3004500	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P4Y
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.21
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	1541000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	0.21
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	35510	usd

Files In Submission

Name	View Source	Status
0001493152-23-017115-index-headers.html	Edgar Link	pending
0001493152-23-017115-index.html	Edgar Link	pending
0001493152-23-017115.txt	Edgar Link	pending
0001493152-23-017115-xbrl.zip	Edgar Link	pending
blpg-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
blpg-20230331_cal.xml	Edgar Link	unprocessable
blpg-20230331_def.xml	Edgar Link	unprocessable
blpg-20230331_lab.xml	Edgar Link	unprocessable
blpg-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLPG
Blue Line Protection Group, Inc. Stock $blpg

2023 Q2 Form 10-Q Financial Statement

#000149315223017115 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLPG Blue Line Protection Group, Inc. Stock $blpg

2023 Q2 Form 10-Q Financial Statement

#000149315223017115 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLPG
Blue Line Protection Group, Inc. Stock $blpg